Genotoxic activity of four metabolites of the soy isoflavone daidzein

被引:26
|
作者
Schmitt, E
Metzler, M
Jonas, R
Dekant, W
Stopper, H
机构
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany
[2] Univ Karlsruhe, Inst Food Chem & Toxicol, D-76131 Karlsruhe, Germany
关键词
phytoestrogens; isoflavones; micronuclei;
D O I
10.1016/j.mrgentox.2003.08.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Products containing phytoestrogens are increasingly promoted as the "natural" alternative to estrogen replacement therapy. In the present study, we have used the in vitro micronucleus assay in L5178Y mouse lymphoma cells to investigate the genotoxic potential of the isoflavone daidzein, and of four daidzein metabolites known to be formed in humans. Whereas no induction of micronuclei was observed with daidzein up to the limit of solubility (100 muM), all four daidzein metabolites, i.e. equol (2.3-fold induction at 100muM), O-desmethylangolensin (6.2-fold induction at 10 muM), 4',6,7-isoflavone (6.7-fold induction at 100 muM) and 3',4',7-isoflavone (8.2-fold induction at 100 muM) induced micronuclei in a concentration-dependent manner. Thus, both reductive and oxidative metabolites of the soy isoflavone daidzein exhibit genotoxic potential in vitro. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
  • [21] Dual effects of daidzein, a soy isoflavone, on catecholamine synthesis and secretion in cultured bovine adrenal medullary cells
    Liu, Minhui
    Yanagihara, Nobuyuki
    Toyohira, Yumiko
    Tsutsui, Masato
    Ueno, Susume
    Shinohara, Yuko
    ENDOCRINOLOGY, 2007, 148 (11) : 5348 - 5354
  • [22] Deconjugation of soy isoflavone glucuronides needed for estrogenic activity
    Islam, M. A.
    Bekele, R.
    vanden Berg, J. H. J.
    Kuswanti, Y.
    Thapa, O.
    Soltani, S.
    van Leeuwen, F. X. R.
    Rietjens, I. M. C. M.
    Murk, A. J.
    TOXICOLOGY IN VITRO, 2015, 29 (04) : 706 - 715
  • [23] Increased expression of catalase in human hepatoma cells by the soy isoflavone, daidzein (vol 102, pg 437, 2008)
    Kampkotter, A.
    Wiegand, C.
    Timpel, C.
    Roehrdanz, E.
    Chovolou, Y.
    Kahl, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 (05) : 489 - 489
  • [24] Soy isoflavone concentrate
    不详
    FOOD AUSTRALIA, 1998, 50 (04): : 176 - 176
  • [25] Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells
    Lehmann, L
    Esch, HL
    Wagner, J
    Rohnstock, L
    Metzler, M
    TOXICOLOGY LETTERS, 2005, 158 (01) : 72 - 86
  • [26] Antileukemic activity of genistein, a major isoflavone present in soy products
    Raynal, Noeel J. -M.
    Momparler, Louise
    Charbonneau, Michel
    Momparler, Richard L.
    JOURNAL OF NATURAL PRODUCTS, 2008, 71 (01): : 3 - 7
  • [27] Evaluation of isoflavone content and antioxidant activity of selected soy taxa
    Szymczak, Grazyna
    Wojciak-Kosior, Magdalena
    Sowa, Ireneusz
    Zapala, Karolina
    Strzernski, Maciej
    Kocjan, Ryszard
    JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2017, 57 : 40 - 48
  • [28] Disposition and biotransformation of the estrogenic isoflavone daidzein in rats
    Bayer, T
    Colnot, T
    Dekant, W
    TOXICOLOGICAL SCIENCES, 2001, 62 (02) : 205 - 211
  • [29] Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women
    Liu, Zhao-min
    Ho, Suzanne C.
    Woo, Jean
    Chen, Yu-ming
    Wong, Carmen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (06): : 653 - 660
  • [30] Antioxidant and free radical scavenging activity of isoflavone metabolites
    Rimbach, G
    De Pascual-Teresa, S
    Ewins, BA
    Matsugo, S
    Uchida, Y
    Minihane, AM
    Turner, R
    VafeiAdou, K
    Weinberg, PD
    XENOBIOTICA, 2003, 33 (09) : 913 - 925